beta-D-Galp-(1->4)-[alpha-L-Rhap-(1->3)]-beta-D-GlcpNAc-OMe

Term ID

CHEBI:145721

Synonyms

alpha-L-Rha-(1->3)-[beta-D-Gal-(1->4)]-beta-D-GlcNAc-OMe
alpha-L-Rhap-(1->3)-[beta-D-Galp-(1->4)]-beta-D-GlcpNAc-OMe
beta-D-Gal-(1->4)-[alpha-L-Rha-(1->3)]-beta-D-GlcNAc-OMe
Galbeta1-4(Rhaalpha1-3)GlcbetaNAcOMe
methyl 6-deoxy-alpha-L-mannopyranosyl-(1->3)-[beta-D-galactopyranosyl-(1->4)]-2-acetamido-2-deoxy-beta-D-glucopyranoside
methyl alpha-L-rhamnopyranosyl-(1->3)-[beta-D-galactopyranosyl-(1->4)]-2-acetamido-2-deoxy-beta-D-glucopyranoside
methyl alpha-L-rhamnosyl-(1->3)-[beta-D-galactosyl-(1->4)]-N-acetyl-beta-D-glucosaminide
methyl beta-D-galactopyranosyl-(1->4)-[alpha-L-rhamnopyranosyl-(1->3)]-2-acetamido-2-deoxy-beta-D-glucopyranoside
methyl beta-D-galactosyl-(1->4)-[alpha-L-rhamnosyl-(1->3)]-N-acetyl-beta-D-glucosaminide
Rhaalpha1-3(Galbeta1-4)GlcbetaNAcOMe
RhaLe(x)OMe

(all 11)

Definition

A methyl glycoside that is beta-D-Galp-(1->4)-[alpha-L-Rhap-(1->3)]-beta-D-GlcpNAc (LacLe(x)) in which the hydroxy group at the reducing-end anomeric centre is methylated.

References

PMID:31666308

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-Galp-(1->4)-[alpha-L-Rhap-(1->3)]-beta-D-GlcpNAc-OMe

Phenotype where environments contain beta-D-Galp-(1->4)-[alpha-L-Rhap-(1->3)]-beta-D-GlcpNAc-OMe

Phenotype modified by environments containing beta-D-Galp-(1->4)-[alpha-L-Rhap-(1->3)]-beta-D-GlcpNAc-OMe

Phenotype affecting beta-D-Galp-(1->4)-[alpha-L-Rhap-(1->3)]-beta-D-GlcpNAc-OMe

Human Disease Model